The ESMO clinical practise guidelines for early breast cancer: diagnosis, treatment and follow-up: on the winding road to personalized medicine
S Loi
Annals of Oncology, Volume 30, Issue 8, August 2019, Pages 1183–1184, https://doi.org/10.1093/annonc/mdz201
Published: 09 July 2019
Cite
Permissions Icon Permissions
 Share
Issue Section: Editorials
In this issue of Annals, Cardoso et al. [1], formulate concise and succinct recommendations for early breast cancer management, which will be a valuable resource for clinicians treating breast cancer patients. Unlike the St Gallen consensus, which is based on panel expert opinion [2], these recommendations serve to bring together the collective literature at the present moment. This year’s edition marks the beginning of significant changes in how we treat patients, now personalized based on biomarkers, in particular gene expression-based assays. In addition, the advent of the first immune biomarker for breast cancer patients is incorporated, as...

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)